PITTSBURGH, Jan. 7, 2025 /PRNewswire/ — Avista Therapeutics, a pre-clinical-stage biotechnology company developing innovative gene therapies for rare ophthalmic conditions, today announced the appointment of Steven Altschuler, MD, as the Chairman of the Board of Directors. Dr. Altschuler…